Faculty of Health Sciences
School of Medicine
Department of Medical Oncology
Medical oncology - Research Output
Research articles in refereed specialist journals:
Vorobiof DA, Rapoport BL, Chasen MR, Slabber CF, McMichael GB, Eek RW, Mohammed C: 2004. First line therapy with paclitaxel (Taxol) and pegylated liposomal doxorubicin (Caelyx) in patients with metastatic breast cancer: A multicentre phase II study. Breast, 13, pp 219-226.
de Wit R, Herrstedt J, Rapoport BL, Carides AD, Guoguang-Ma J, Elmer M, Schmidt C, Evans D, Horgan KJ: 2004. The oral NK[1] antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapy: a combined analysis of two randomised placebo-controlled phase III clinical trials. European Journal of Cancer, 40, pp 403-410.
Wadler S, Levy D, Frederickson HL, Falkson CI, Wang Y, Weller EA, Burk R, Ho G, Kadish AS: 2004. Phase II trial of interleukin-12 in patients with advanced cervical cancer : Clinical and immunologic correlates Eastern Cooperative Oncology Group Study E1E96. Gynecologic Oncology, 92 (3), pp 957-964.
|
